Royal Bank of Canada
OCAT

Royal Bank of Canada’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Royal Bank of Canada’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,432
Closed -$12K – 7016
2015
Q4 		$12K Sell
1,432
-2,285
-61% -$15.3K ﹤0.01% 5923
2015
Q3 		$16K Sell
3,717
-305
-8% -$1.33K ﹤0.01% 5673
2015
Q2 		$21K Buy
4,022
+2,404
+149% +$15.4K ﹤0.01% 5691
2015
Q1 		$10K Buy
+1,618
New +$10.4K ﹤0.01% 5583

Royal Bank of Canada's OCAT Position: Q1 2016 in Review

Royal Bank of Canada sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 1,432 shares — an estimated $12K sold.

Royal Bank of Canada first reported a position in OCAT in Q1 2015 and held it in 4 quarters. The position peaked at $21K in Q2 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Royal Bank of Canada reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 1,432 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $12K.
  • Royal Bank of Canada first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q1 2015 and held it in 4 quarters.
  • Royal Bank of Canada's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $21K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Royal Bank of Canada's 13F filing for Q1 2016, filed 16 May 2016.